Environmental modifiable risk factors for multiple sclerosis: Report from the 2016 ECTRIMS focused workshop
暂无分享,去创建一个
David H. Miller | X. Montalban | T. Derfuss | R. Liblau | M. Amato | P. Soelberg Sørensen | B. Hemmer | David H. Miller
[1] H. Tremlett,et al. Factors associated with onset, relapses or progression in multiple sclerosis: A systematic review , 2017, Neurotoxicology.
[2] D. Younger,et al. Epidemiology of Multiple Sclerosis. , 2016, Neurologic clinics.
[3] Ba,et al. Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk , 2016, Neurology: Genetics.
[4] Altmann,et al. Phase 2 baseline versus treatment clinical trial of the HIV drug raltegravir in patients with active relapsing remitting multiple sclerosis: the INSPIRE study results , 2016 .
[5] Laura M Cox,et al. Alterations of the human gut microbiome in multiple sclerosis , 2016, Nature Communications.
[6] Krishna R. Kalari,et al. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls , 2016, Scientific Reports.
[7] H. Butzkueven,et al. Observational data: Understanding the real MS world , 2016, Multiple sclerosis.
[8] A. Ascherio,et al. Vitamin D Status During Pregnancy and Risk of Multiple Sclerosis in Offspring of Women in the Finnish Maternity Cohort. , 2016, JAMA neurology.
[9] E. Waubant,et al. Gut microbiota composition and relapse risk in pediatric MS: A pilot study , 2016, Journal of the Neurological Sciences.
[10] C. Wolfson,et al. Health-related quality of life in multiple sclerosis , 2016, Neurology.
[11] R. Marrie,et al. Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis , 2016, Neurology.
[12] A. Ascherio,et al. Epidemiology of Multiple Sclerosis: From Risk Factors to Prevention—An Update , 2016, Seminars in Neurology.
[13] T. Dwyer,et al. Population attributable fractions and joint effects of key risk factors for multiple sclerosis , 2016, Multiple sclerosis.
[14] E. Mowry,et al. High consumption of coffee is associated with decreased multiple sclerosis risk; results from two independent studies , 2016, Journal of Neurology, Neurosurgery & Psychiatry.
[15] H. Wiendl,et al. Implications of dietary salt intake for multiple sclerosis pathogenesis , 2016, Multiple sclerosis.
[16] T. Dwyer,et al. Frequency of Comorbidities and Their Association with Clinical Disability and Relapse in Multiple Sclerosis , 2016, Neuroepidemiology.
[17] B. Hemmer,et al. B cell-directed therapies in multiple sclerosis. , 2016, Neurodegenerative disease management.
[18] D. Goodin,et al. Association of Vitamin D Levels With Multiple Sclerosis Activity and Progression in Patients Receiving Interferon Beta-1b. , 2015, JAMA neurology.
[19] T. Holmøy,et al. Body mass index influence interferon-beta treatment response in multiple sclerosis , 2015, Journal of Neuroimmunology.
[20] M. Bottai,et al. Effect of Smoking Cessation on Multiple Sclerosis Prognosis. , 2015, JAMA neurology.
[21] C. Greenwood,et al. Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study , 2015, PLoS medicine.
[22] J. Hillert,et al. The Swedish MS registry – clinical support tool and scientific resource , 2015, Acta neurologica Scandinavica.
[23] C. Wolfson,et al. Is high socioeconomic status a risk factor for multiple sclerosis? A systematic review , 2015, European journal of neurology.
[24] D. Hafler,et al. Multiple sclerosis—a quiet revolution , 2015, Nature Reviews Neurology.
[25] B. Hemmer,et al. Role of the innate and adaptive immune responses in the course of multiple sclerosis , 2015, The Lancet Neurology.
[26] E. Granieri,et al. Body size and the risk of multiple sclerosis in Norway and Italy: The EnvIMS study , 2015, Multiple sclerosis.
[27] M. Ramanathan,et al. Cardiovascular risk factors are associated with increased lesion burden and brain atrophy in multiple sclerosis , 2015, Journal of Neurology, Neurosurgery & Psychiatry.
[28] H. Siebner,et al. Trichuris suis ova therapy in relapsing multiple sclerosis is safe but without signals of beneficial effect , 2015, Multiple sclerosis.
[29] M. Niino,et al. Genetic polymorphisms related to vitamin D and the therapeutic potential of vitamin D in multiple sclerosis. , 2015, Canadian journal of physiology and pharmacology.
[30] R. Khanna,et al. The Development of Prophylactic and Therapeutic EBV Vaccines. , 2015, Current topics in microbiology and immunology.
[31] R. Zheng,et al. Chronic caffeine treatment protects against experimental autoimmune encephalomyelitis in mice: Therapeutic window and receptor subtype mechanism , 2014, Neuropharmacology.
[32] P. Bhargava,et al. The vitamin D to ameliorate multiple sclerosis (VIDAMS) trial: study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis. , 2014, Contemporary clinical trials.
[33] T. Olsson,et al. Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors. , 2014, Obesity research & clinical practice.
[34] B. V. Pedersen,et al. Stressful life-events in childhood and risk of multiple sclerosis: a Danish nationwide cohort study , 2014, Multiple sclerosis.
[35] T. Olsson,et al. Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis , 2014, Neurology.
[36] N. Nielsen,et al. Major stressful life events in adulthood and risk of multiple sclerosis , 2014, Journal of Neurology, Neurosurgery & Psychiatry.
[37] T. Olsson,et al. Alcohol as a modifiable lifestyle factor affecting multiple sclerosis risk. , 2014, JAMA neurology.
[38] Ludwig Kappos,et al. Vitamin D as an early predictor of multiple sclerosis activity and progression. , 2014, JAMA neurology.
[39] C. Pozzilli,et al. Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS , 2014, Neurology.
[40] T. Olsson,et al. Smoking and multiple sclerosis susceptibility , 2013, European Journal of Epidemiology.
[41] J. Pakpoor,et al. Childhood obesity and risk of pediatric multiple sclerosis and clinically isolated syndrome , 2013, Neurology.
[42] M. Pirinen,et al. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis , 2013, Nature Genetics.
[43] G. Hallmans,et al. Smoking as a risk factor for multiple sclerosis , 2013, Multiple sclerosis.
[44] C. Tench,et al. Tobacco smoking and disability progression in multiple sclerosis: United Kingdom cohort study , 2013, Brain : a journal of neurology.
[45] K. Dear,et al. The physical anthropometry, lifestyle habits and blood pressure of people presenting with a first clinical demyelinating event compared to controls: The Ausimmune study , 2013, Multiple sclerosis.
[46] T. Sørensen,et al. Childhood body mass index and multiple sclerosis risk: a long-term cohort study , 2013, Multiple sclerosis.
[47] A. Ascherio,et al. Caffeine and alcohol intakes have no association with risk of multiple sclerosis , 2013, Multiple sclerosis.
[48] C. A. Speck-Hernandez,et al. Organic Solvents as Risk Factor for Autoimmune Diseases: A Systematic Review and Meta-Analysis , 2012, PloS one.
[49] J. Lünemann,et al. The initiation and prevention of multiple sclerosis , 2012, Nature Reviews Neurology.
[50] R. Spang,et al. T cells become licensed in the lung to enter the central nervous system , 2012, Nature.
[51] M. Filippi,et al. A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[52] S. Mellgren,et al. Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial , 2012, Multiple sclerosis.
[53] T. Olsson,et al. High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women , 2012, Multiple sclerosis.
[54] F. Paul,et al. Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial , 2012, Trials.
[55] F. Barkhof,et al. Efficacy of vitamin D3 as add-on therapy in patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial , 2011, Journal of the Neurological Sciences.
[56] D. Dreyfus. Autoimmune disease: A role for new anti-viral therapies? , 2011, Autoimmunity reviews.
[57] K. Berer,et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination , 2011, Nature.
[58] M. Stein,et al. A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis , 2011, Neurology.
[59] K. Myhr,et al. Dietary Vitamin D3 Supplements Reduce Demyelination in the Cuprizone Model , 2011, PloS one.
[60] J. Correale,et al. The impact of environmental infections (parasites) on MS activity , 2011, Multiple sclerosis.
[61] Simon C. Potter,et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.
[62] A. Ascherio,et al. Smoking and increased risk of multiple sclerosis: parallel trends in the sex ratio reinforce the evidence. , 2011, Annals of Epidemiology.
[63] A. Bar-Or,et al. Cholecalciferol plus calcium suppresses abnormal PBMC reactivity in patients with multiple sclerosis. , 2011, The Journal of clinical endocrinology and metabolism.
[64] G. Giovannoni,et al. Smoking and Multiple Sclerosis: An Updated Meta-Analysis , 2011, PloS one.
[65] P. Kokhaei,et al. Therapeutic Effect of Vitamin D3 in Multiple Sclerosis Patients , 2011, Immunological investigations.
[66] J. Damoiseaux,et al. Vitamin D as a T-cell modulator in multiple sclerosis. , 2011, Vitamins and hormones.
[67] S. Mazmanian,et al. Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis , 2010, Proceedings of the National Academy of Sciences.
[68] G. Giovannoni,et al. Multiple sclerosis: risk factors, prodromes, and potential causal pathways , 2010, The Lancet Neurology.
[69] J. M. Burton,et al. A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis , 2010, Neurology.
[70] A. Ascherio,et al. Primary infection with the Epstein‐Barr virus and risk of multiple sclerosis , 2010, Annals of neurology.
[71] Jing Cui,et al. Integration of genetic risk factors into a clinical algorithm for multiple sclerosis susceptibility: a weighted genetic risk score , 2009, The Lancet Neurology.
[72] T. Chitnis,et al. Body size and risk of MS in two cohorts of US women , 2009, Neurology.
[73] G. Ebers,et al. Multiple sclerosis: major histocompatibility complexity and antigen presentation , 2009, Genome Medicine.
[74] T. Olsson,et al. Tobacco smoking, but not Swedish snuff use, increases the risk of multiple sclerosis , 2009, Neurology.
[75] R. Marrie,et al. Comorbidity delays diagnosis and increases disability at diagnosis in MS , 2009, Neurology.
[76] Ariel Miller,et al. Impact of exposure to war stress on exacerbations of multiple sclerosis , 2008, Annals of neurology.
[77] A. Lutterotti,et al. Smoking is a risk factor for early conversion to clinically definite multiple sclerosis , 2008, Multiple sclerosis.
[78] A. Ascherio,et al. Environmental risk factors for multiple sclerosis. Part I: The role of infection , 2007, Annals of neurology.
[79] A. Ascherio,et al. Infectious mononucleosis and risk for multiple sclerosis: A meta‐analysis , 2006, Annals of neurology.
[80] D. Mohr,et al. The role of stress-response systems for the pathogenesis and progression of MS. , 2005, Trends in immunology.
[81] V. De Rosa,et al. Leptin increase in multiple sclerosis associates with reduced number of CD4(+)CD25+ regulatory T cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[82] D. Gilden. Infectious causes of multiple sclerosis , 2005, The Lancet Neurology.
[83] D. Mohr,et al. Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis , 2004, BMJ : British Medical Journal.
[84] C. Johansen,et al. The risk of multiple sclerosis in bereaved parents , 2004, Neurology.
[85] Graham M Lord,et al. Requirement for Leptin in the Induction and Progression of Autoimmune Encephalomyelitis1 , 2001, The Journal of Immunology.
[86] C. Martyn,et al. Migrant studies in multiple sclerosis , 1995, Progress in Neurobiology.
[87] A. Sadovnick,et al. Genetics of Multiple Sclerosis , 1995, Neurologic clinics.